Boehringer Ingelheim GmbH / Daewoong
Completed divestiture of Boehringer Ingelheim’s and SSP’s portfolio of Korean and Japanese subsidiaries.
Completed divestiture via carve-out of Boehringer Ingelheim SSP’s prescription generics business in Japan (Total sales €100m in 2003) including a 3 months’ deal-shaping phase and a subsequent 6 months marketing and negotiation phase including an international auction process for a total consideration of JPY 20.2B . Led the Management Presentations and participated in final negotiations.